aluates Reports

$ 0.0

Automative

Global Quadrivalent Flu Vaccine Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-20H613

Global Quadrivalent Flu Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Quadrivalent Flu Vaccine Market Research Report 2024

Code: QYRE-Auto-20H613

Report

January 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Quadrivalent Flu Vaccine Market Size

The global Quadrivalent Flu Vaccine market was valued at US$ 5284.8 million in 2023 and is anticipated to reach US$ 7697.8 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.

Quadrivalent Flu Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Quadrivalent Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Flu Vaccine.

Report Scope

The Quadrivalent Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quadrivalent Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Quadrivalent Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Quadrivalent Flu Vaccine Market Report

Report Metric	Details
Report Name	Quadrivalent Flu Vaccine Market
Accounted market size in 2023	US$ 5284.8 million
Forecasted market size in 2030	US$ 7697.8 million
CAGR	5.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Intramuscular Injection Nasal Spray Intradermal Shot
Segment by Application	Hospital Clinic Public Health Agency Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quadrivalent Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quadrivalent Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Quadrivalent Flu Vaccine Market growing?

Ans: The Quadrivalent Flu Vaccine Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Quadrivalent Flu Vaccine Market size in 2030?

Ans: The Quadrivalent Flu Vaccine Market size in 2030 will be US$ 7697.8 million.

Who are the main players in the Quadrivalent Flu Vaccine Market report?

Ans: The main players in the Quadrivalent Flu Vaccine Market are Sanofi Pasteur, AstraZeneca, CSL, Abbott, GlaxoSmithKline

What are the Application segmentation covered in the Quadrivalent Flu Vaccine Market report?

Ans: The Applications covered in the Quadrivalent Flu Vaccine Market report are Hospital, Clinic, Public Health Agency, Other

What are the Type segmentation covered in the Quadrivalent Flu Vaccine Market report?

Ans: The Types covered in the Quadrivalent Flu Vaccine Market report are Intramuscular Injection, Nasal Spray, Intradermal Shot

1 Quadrivalent Flu Vaccine Market Overview

1.1 Product Overview and Scope of Quadrivalent Flu Vaccine

1.2 Quadrivalent Flu Vaccine Segment by Type

1.2.1 Global Quadrivalent Flu Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Intramuscular Injection

1.2.3 Nasal Spray

1.2.4 Intradermal Shot

1.3 Quadrivalent Flu Vaccine Segment by Application

1.3.1 Global Quadrivalent Flu Vaccine Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Public Health Agency

1.3.5 Other

1.4 Global Quadrivalent Flu Vaccine Market Size Estimates and Forecasts

1.4.1 Global Quadrivalent Flu Vaccine Revenue 2019-2030

1.4.2 Global Quadrivalent Flu Vaccine Sales 2019-2030

1.4.3 Global Quadrivalent Flu Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Quadrivalent Flu Vaccine Market Competition by Manufacturers

2.1 Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Quadrivalent Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Quadrivalent Flu Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Quadrivalent Flu Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Type & Application

2.7 Quadrivalent Flu Vaccine Market Competitive Situation and Trends

2.7.1 Quadrivalent Flu Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Quadrivalent Flu Vaccine Players Market Share by Revenue

2.7.3 Global Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Quadrivalent Flu Vaccine Retrospective Market Scenario by Region

3.1 Global Quadrivalent Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Quadrivalent Flu Vaccine Global Quadrivalent Flu Vaccine Sales by Region: 2019-2030

3.2.1 Global Quadrivalent Flu Vaccine Sales by Region: 2019-2024

3.2.2 Global Quadrivalent Flu Vaccine Sales by Region: 2025-2030

3.3 Global Quadrivalent Flu Vaccine Global Quadrivalent Flu Vaccine Revenue by Region: 2019-2030

3.3.1 Global Quadrivalent Flu Vaccine Revenue by Region: 2019-2024

3.3.2 Global Quadrivalent Flu Vaccine Revenue by Region: 2025-2030

3.4 North America Quadrivalent Flu Vaccine Market Facts & Figures by Country

3.4.1 North America Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Quadrivalent Flu Vaccine Sales by Country (2019-2030)

3.4.3 North America Quadrivalent Flu Vaccine Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Quadrivalent Flu Vaccine Market Facts & Figures by Country

3.5.1 Europe Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Quadrivalent Flu Vaccine Sales by Country (2019-2030)

3.5.3 Europe Quadrivalent Flu Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Quadrivalent Flu Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Quadrivalent Flu Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Quadrivalent Flu Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Quadrivalent Flu Vaccine Market Facts & Figures by Country

3.7.1 Latin America Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Quadrivalent Flu Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Quadrivalent Flu Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Quadrivalent Flu Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Quadrivalent Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Quadrivalent Flu Vaccine Sales by Type (2019-2030)

4.1.1 Global Quadrivalent Flu Vaccine Sales by Type (2019-2024)

4.1.2 Global Quadrivalent Flu Vaccine Sales by Type (2025-2030)

4.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Quadrivalent Flu Vaccine Revenue by Type (2019-2030)

4.2.1 Global Quadrivalent Flu Vaccine Revenue by Type (2019-2024)

4.2.2 Global Quadrivalent Flu Vaccine Revenue by Type (2025-2030)

4.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Quadrivalent Flu Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Quadrivalent Flu Vaccine Sales by Application (2019-2030)

5.1.1 Global Quadrivalent Flu Vaccine Sales by Application (2019-2024)

5.1.2 Global Quadrivalent Flu Vaccine Sales by Application (2025-2030)

5.1.3 Global Quadrivalent Flu Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Quadrivalent Flu Vaccine Revenue by Application (2019-2030)

5.2.1 Global Quadrivalent Flu Vaccine Revenue by Application (2019-2024)

5.2.2 Global Quadrivalent Flu Vaccine Revenue by Application (2025-2030)

5.2.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Quadrivalent Flu Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Quadrivalent Flu Vaccine Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 CSL

6.3.1 CSL Corporation Information

6.3.2 CSL Description and Business Overview

6.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 CSL Quadrivalent Flu Vaccine Product Portfolio

6.3.5 CSL Recent Developments/Updates

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Description and Business Overview

6.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Abbott Quadrivalent Flu Vaccine Product Portfolio

6.4.5 Abbott Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Quadrivalent Flu Vaccine Industry Chain Analysis

7.2 Quadrivalent Flu Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Quadrivalent Flu Vaccine Production Mode & Process

7.4 Quadrivalent Flu Vaccine Sales and Marketing

7.4.1 Quadrivalent Flu Vaccine Sales Channels

7.4.2 Quadrivalent Flu Vaccine Distributors

7.5 Quadrivalent Flu Vaccine Customers

8 Quadrivalent Flu Vaccine Market Dynamics

8.1 Quadrivalent Flu Vaccine Industry Trends

8.2 Quadrivalent Flu Vaccine Market Drivers

8.3 Quadrivalent Flu Vaccine Market Challenges

8.4 Quadrivalent Flu Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Quadrivalent Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Quadrivalent Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Quadrivalent Flu Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Quadrivalent Flu Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Quadrivalent Flu Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Quadrivalent Flu Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Quadrivalent Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Quadrivalent Flu Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Quadrivalent Flu Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Quadrivalent Flu Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Quadrivalent Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Flu Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Quadrivalent Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Quadrivalent Flu Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Quadrivalent Flu Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Quadrivalent Flu Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Quadrivalent Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Quadrivalent Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Quadrivalent Flu Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Quadrivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Quadrivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Quadrivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Quadrivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Quadrivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Quadrivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Quadrivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Quadrivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Quadrivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Quadrivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Quadrivalent Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Quadrivalent Flu Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Quadrivalent Flu Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Quadrivalent Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Quadrivalent Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Quadrivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Quadrivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Quadrivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Quadrivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Quadrivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Quadrivalent Flu Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Quadrivalent Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Quadrivalent Flu Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Quadrivalent Flu Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Quadrivalent Flu Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Type (2019-2024)

Table 59. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Type (2025-2030)

Table 60. Global Quadrivalent Flu Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Quadrivalent Flu Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Quadrivalent Flu Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Quadrivalent Flu Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Quadrivalent Flu Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Application (2019-2024)

Table 69. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Application (2025-2030)

Table 70. Sanofi Pasteur Corporation Information

Table 71. Sanofi Pasteur Description and Business Overview

Table 72. Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Sanofi Pasteur Quadrivalent Flu Vaccine Product

Table 74. Sanofi Pasteur Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. AstraZeneca Quadrivalent Flu Vaccine Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. CSL Corporation Information

Table 81. CSL Description and Business Overview

Table 82. CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. CSL Quadrivalent Flu Vaccine Product

Table 84. CSL Recent Developments/Updates

Table 85. Abbott Corporation Information

Table 86. Abbott Description and Business Overview

Table 87. Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Abbott Quadrivalent Flu Vaccine Product

Table 89. Abbott Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Quadrivalent Flu Vaccine Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Quadrivalent Flu Vaccine Distributors List

Table 98. Quadrivalent Flu Vaccine Customers List

Table 99. Quadrivalent Flu Vaccine Market Trends

Table 100. Quadrivalent Flu Vaccine Market Drivers

Table 101. Quadrivalent Flu Vaccine Market Challenges

Table 102. Quadrivalent Flu Vaccine Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Quadrivalent Flu Vaccine

Figure 2. Global Quadrivalent Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Quadrivalent Flu Vaccine Market Share by Type in 2023 & 2030

Figure 4. Intramuscular Injection Product Picture

Figure 5. Nasal Spray Product Picture

Figure 6. Intradermal Shot Product Picture

Figure 7. Global Quadrivalent Flu Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Quadrivalent Flu Vaccine Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Public Health Agency

Figure 12. Other

Figure 13. Global Quadrivalent Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Quadrivalent Flu Vaccine Market Size (2019-2030) & (US$ Million)

Figure 15. Global Quadrivalent Flu Vaccine Sales (2019-2030) & (K Doses)

Figure 16. Global Quadrivalent Flu Vaccine Average Price (USD/Dose) & (2019-2030)

Figure 17. Quadrivalent Flu Vaccine Report Years Considered

Figure 18. Quadrivalent Flu Vaccine Sales Share by Manufacturers in 2023

Figure 19. Global Quadrivalent Flu Vaccine Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Quadrivalent Flu Vaccine Players: Market Share by Revenue in 2023

Figure 21. Quadrivalent Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Quadrivalent Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Quadrivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 24. North America Quadrivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Quadrivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 28. Europe Quadrivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 29. Germany Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share by Region (2019-2030)

Figure 36. China Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Quadrivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 47. Latin America Quadrivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Quadrivalent Flu Vaccine Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Quadrivalent Flu Vaccine Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Quadrivalent Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Quadrivalent Flu Vaccine by Type (2019-2030)

Figure 57. Global Revenue Market Share of Quadrivalent Flu Vaccine by Type (2019-2030)

Figure 58. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Type (2019-2030)

Figure 59. Global Sales Market Share of Quadrivalent Flu Vaccine by Application (2019-2030)

Figure 60. Global Revenue Market Share of Quadrivalent Flu Vaccine by Application (2019-2030)

Figure 61. Global Quadrivalent Flu Vaccine Price (USD/Dose) by Application (2019-2030)

Figure 62. Quadrivalent Flu Vaccine Value Chain

Figure 63. Quadrivalent Flu Vaccine Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions